🌅 Today's Morning Call
|
S&P Futures
7,518.25
▼ -16.75 (-0.22%)
|
Nasdaq Futures
29,057.75
▼ -139.25 (-0.48%)
|
Dow Futures
52,330.00
▼ -54.00 (-0.10%)
|
|
10Y Treasury
4.63%
▲ +0.03%
|
US Dollar
101.15
▲ +0.01 (+0.01%)
|
Bitcoin
$65,879
▼ -$637 (-0.96%)
|
Data as of 8:07 AM ET
Good morning! It is Wednesday, July 22, 2026, and futures are pointing to a soft open with the S&P 500 off about 0.22%, the Nasdaq down 0.48%, and the Dow slipping a modest 0.10%. Treasury yields are ticking higher across the board, which is keeping a lid on risk appetite this morning. From FDA clearances to M&A deals to a foodborne illness outbreak at Taco Bell, there is plenty on the tape. Here is what is moving markets before the bell.
👀 What to Watch Today
Traders will want to keep eyes on the broader financials sector today after Goldman Sachs and Morgan Stanley delivered blockbuster quarters that have analysts raising estimates and upgrading targets. The question now is whether that strength can ripple out to regional banks and other Wall Street-adjacent names when their numbers come in.On the macro side, rising Treasury yields deserve attention. The 10-year is sitting at 4.63% and the 30-year is holding above 5.13%, both nudging higher overnight. That combination tends to pressure growth and tech names, which explains why the Nasdaq is underperforming futures this morning.
Watch for any further commentary out of Washington on pharmaceutical tariffs. Sandoz (SDZNY) confirmed it is in active talks with U.S. policymakers after President Trump renewed tariff threats against drugmakers who do not manufacture domestically. Any escalation or resolution there could move the broader healthcare and generics space.
Your Phone Is Smarter Than Your Inbox
Not every market move can wait. Our text alerts deliver the ones that can't. One short alert, straight to your phone, when something is worth seeing now. No fluff. No noise. No charge.
Text Me the Alerts🌏 Overnight Recap
Overseas, Airbus (EADSF, EADSY) was the standout story in European trading, with shares jumping nearly 5% after the planemaker launched a 5 billion euro share buyback and unveiled new midterm profit targets that include nearly doubling earnings. That kind of shareholder-friendly move tends to get attention, and it is worth watching whether aerospace and defense names stateside take any cues.Also in Europe, Deutsche Bank (DB) is dealing with an unwelcome development. German tax investigators raided the bank's Frankfurt headquarters in connection with a probe into so-called cum-cum transactions, a type of dividend stripping scheme. That is a headline that will follow DB into the U.S. trading session and could weigh on the stock.
In crypto markets, Bitcoin slipped below $66,000 overnight, down roughly 0.96%, adding to a cautious tone in digital assets. Meanwhile, Coinbase (COIN) resolved its FOIA lawsuit with the SEC over lost messages, a small but symbolically notable step toward clearer regulatory relations between crypto exchanges and U.S. watchdogs.
Sponsored Content
The Technology Big Tech Is Betting On After AI
.gif)
It isn't a chip.
It isn't software.
And it isn't a data center.
Bill Gates backed it. Jeff Bezos invested in it. Google signed a deal for it. Microsoft committed billions toward it.
Karim Rahemtulla believes one little-known company could sit at the center of what may become America's most important energy buildout-and a major government milestone expected this August could bring the story into the spotlight.
📊 Pre-Market Movers
Johnson and Johnson (JNJ) is drawing attention this morning after the FDA granted marketing authorization for its robotic surgery system. This puts JNJ in direct competition with Intuitive Surgical (ISRG), which has long dominated the robotic surgery space. Expect both names to see elevated activity at the open.Repligen (RGEN) and BioLife Solutions (BLFS) are in focus following the announcement of a $1.5 billion cash-and-stock acquisition. BLFS shareholders are likely to see a premium reflected in pre-market trading, while RGEN investors will be processing what the deal means for the company's growth trajectory in cell and gene therapy infrastructure.
Yum Brands (YUM) is on watch after a cyclosporiasis outbreak linked to shredded lettuce at Taco Bell locations made headlines. Analysts are calling it a near-term sales headwind rather than a structural problem, but the story has legs and YUM could see volatility until the situation is contained and fully communicated to investors.
Sell this, buy that [ad]
🔍 Today's Watchlist
- JNJ: FDA just cleared its robotic surgery device, opening a new competitive front against Intuitive Surgical (ISRG)
- RGEN and BLFS: Repligen's $1.5 billion acquisition of BioLife Solutions puts cell therapy infrastructure in the spotlight
- YUM: Taco Bell's cyclosporiasis outbreak is hitting sales headlines, analysts say damage is limited but watch for consumer sentiment data
- 10-Year Treasury at 4.63%: Continued yield creep could pressure rate-sensitive sectors including utilities and real estate
- PLD and SEGXF: A major Prologis bid for UK warehouse giant Segro is heating up with a key shareholder pushing for negotiations
Sponsored Content
Trump Admin to Pump $1 Billion into this "Off-the-Radar" AI Stock
The U.S. government pumped more than $1 billion into Intel. The stock popped 128%. It pumped $400 million into MP Materials. The stock popped 200%. It bought 10% of Trilogy Metals. The stock popped 500%. And now, Trump has chosen this AI stock for a $1 billion payday.
🎯 The Morning Playbook
Today feels like a session where the news flow matters more than the macro backdrop. Futures are modestly red, but the individual stock stories are rich. JNJ's FDA win, the RGEN-BLFS deal, and the Prologis-Segro saga all offer specific sector angles that active traders can work with regardless of the index direction.For longer-term investors, the Goldman and Morgan Stanley earnings lift is worth monitoring as a signal about the health of capital markets broadly. If Wall Street's biggest banks are printing record quarters and raising guidance, the M&A and IPO pipeline for the second half of 2026 could be stronger than the market is currently pricing.
Keep your head on a swivel with yields today. A further push higher in the 10-year toward 4.70% would likely add pressure to growth names and could turn a modest down day into something more uncomfortable. Patience and selectivity are the words of the morning.
📰 Further Reading
The 2026 Elon Crash (Ad)
Every bank in America is now facing an imminent crisis. One that could see trillions of dollars rush out of the traditional financial sector… and into a new store of wealth . Ultimately, this could trigger a collapse of the entire banking system. The catalyst isn't the war in Iran, rate cuts, or pum...
Click here for the full details.
2026 Is Already Setting the Stage — These 3 Names Caught Our Eye (Ad)
The biggest market opportunities don't wait for headlines — by the time the news breaks, the real move is often over. That's why we do the work early, and right now we're watching three small-cap companies that align with conditions historically preceding major market attention in 2026.
Read The Full Story
Elon is hiding something massive in Fremont, California… (Ad)
After a recent visit to Tesla’s private factory in Fremont, California… The legendary angel investor who backed Uber and Robinhood early tweeted: "Nobody will remember that Tesla ever made a car. They will only remember [Elon’s new technology]… It is going to be the most transformative technology pr...
Click here to see what he found